C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
10/2011
10/13/2011	US20110250601 Bisulfite Conversion of DNA
10/13/2011	US20110250599 Methods and Compositions to Detect Nucleic Acids in a Biological Sample
10/13/2011	US20110250587 Novel method for generation of rna virus
10/13/2011	US20110250584 Method for Screening Cancer Therapeutic Agent Using Galectin-3, GSK-3Betta, and Fascin-1
10/13/2011	US20110250583 Optimized probes and primers and methods of using same for the binding, detection, differentiation, isolation and sequencing of influenza a; influenza b; novel influenza a/h1n1; and a novel influenza a/h1n1 rna sequence mutation associated with oseltamivir resistance
10/13/2011	US20110250342 PUFA Polyketide Synthase Systems and Uses Thereof
10/13/2011	US20110250300 Compositions and methods for the treatment or prevention of disorders relating to oxidative stress
10/13/2011	US20110250258 Tumor-specific delivery of therapeutic agents via liposomase
10/13/2011	US20110250223 Hybrid and tandem expression of neisserial proteins
10/13/2011	US20110250221 Group A Streptococcus Pharmaceutical Compositions and Methods Thereof
10/13/2011	US20110250214 Drug delivery system toward demyelinating lesion and biochemical marker of demyelinating lesion
10/13/2011	US20110250211 Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins
10/13/2011	US20110250210 Neutralizing Antibodies and Fragments Thereof Directed Against Platelet Factor-4 Variant 1 (PF4V1)
10/13/2011	US20110250207 Anti-fxi antibodies and methods of use
10/13/2011	US20110250204 Methods and compositions for diagnosing and treating diseases
10/13/2011	US20110250202 Reagents, methods, and systems for detecting methicillin-resistant staphylococcus
10/13/2011	US20110250195 Antibodies Against IL-25
10/13/2011	US20110250193 Composition comprising expression or activity inhibitors of ninjurin1 for the prevention and treatment of inflammatory disease
10/13/2011	US20110250175 Tlr7 ligand and uses thereof
10/13/2011	US20110250130 Tnf-alpha binding proteins
10/13/2011	CA2795750A1 Modulation of cetp expression
10/13/2011	CA2792942A1 Novel single chemical entities and methods for delivery of oligonucleotides
10/13/2011	CA2792561A1 Compositions and methods for inhibiting expression of cd274/pd-l1 gene
10/12/2011	EP2374890A2 Fen-1 endonucleases, mixtures and cleavage methods
10/12/2011	EP2374885A2 ENA nucleic acid drugs modifying splicing in mRNA precursor
10/12/2011	EP2374811A1 IgG Fc/HIV-gp120/c3d fusion protein
10/12/2011	EP2373807A1 Pcr-based method of synthesizing a nucleic acid molecule
10/12/2011	EP2373301A2 Methods of diagnosing and treating motor neuron diseases
10/12/2011	CN102216320A Solvent resistant diafiltration of peptides, pna or oligonucleotides
10/12/2011	CN102212614A Methods of amplifying and sequencing nucleic acids
10/12/2011	CN102212065A Isonucleoside compound or ortho-phosphite derivative thereof and preparation method and application thereof
10/12/2011	CN101225383B RNA interference sequence and recombinant interference plasmid of fucosyl transferase I and IV for suppressing synthesis of LeY carbohydrate antigen
10/12/2011	CN101006177B An improved method for synthesising templated molecules
10/11/2011	US8034992 Gibberellin 2-oxidase genes and uses thereof
10/11/2011	US8034928 Fluorescence assays with improved sensitivity
10/11/2011	US8034924 Process for production of crystal of purine nucleoside compound
10/11/2011	US8034923 Reagents for reversibly terminating primer extension
10/11/2011	US8034922 Compositions and methods for modulating activity of capped small RNAs
10/11/2011	US8034921 IRNA agents targeting CCR5 expressing cells and uses thereof
10/11/2011	US8034920 Nucleic acid primers and probes for detecting breast cells
10/11/2011	US8034919 Probe, probe set, probe carrier, and testing method
10/11/2011	US8034918 Probe, probe set, probe carrier, and testing method
10/11/2011	US8034917 Primer-directed chromosome painting
10/11/2011	US8034916 Expression control elements from the Lemnaceae family
10/11/2011	US8034915 Gene expression construct
10/11/2011	US8034914 Nucleic acid constructs, pharmaceutical compositions and methods of using same for treating cancer
10/11/2011	US8034913 Recombinantly modified plasmin
10/11/2011	US8034912 Parallel preparation of high fidelity probes in an array format
10/11/2011	US8034911 Nucleic acid anchoring system comprising covalent linkage of an oligonucleotide to a solid support
10/11/2011	US8034910 SUMO fusion protein expression system for producing native proteins
10/11/2011	US8034909 Oligonucleotide analogues
10/11/2011	US8034907 Polynucleotides encoding soluble, stable forms of human double minute 2 polypeptides
10/11/2011	US8034794 Methods and compositions for acid phosphatase-1 gene inhibition
10/11/2011	US8034792 Insulin-like growth factor binding protein 7 for treatment of cancer
10/11/2011	US8034791 Activation of Egr-1 promoter by DNA damaging chemotherapeutics
10/11/2011	US8034789 Antisense compounds targeted to connexins and methods of use thereof
10/11/2011	US8034764 Modulation of SOCS expression in therapeutic regimens
10/11/2011	US8034763 Platelet aggregation inhibitor composition
10/11/2011	US8034614 Fluorescent protein
10/11/2011	US8034603 Nucleic acid molecule
10/11/2011	US8034600 Polypeptides having alpha-amylase and granular starch hydrolyzing activity
10/11/2011	US8034598 Engineered cleavage half-domains
10/11/2011	US8034595 Biocatalysts; mutant and/or chemically modified enzymes; stereoselectively hydrolyze an amino nitrile or cyanohydrin intermediate to produce the corresponding carboxylic acid; e.g. phenylglycinonitrile from benzaldehyde, potassium cyanide and ammonium chloride
10/11/2011	US8034593 Multimeric oxidoreductases
10/11/2011	US8034591 Eukaryotic host cell with the ability to directly isomerize xylose into xylulose; ethanol fermentation
10/11/2011	US8034590 Expression of granular starch hydrolyzing enzymes in trichoderma and process for producing glucose from granular starch substrates
10/11/2011	US8034588 Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories
10/11/2011	US8034566 Enhanced sequencing by hybridization using pools of probes
10/11/2011	US8034564 Using mutation in glucose transport protein as evaluative tool in diagnosing/prognosing diabbetic and eating disorders
10/11/2011	US8034561 HIN-1, a tumor suppressor gene
10/11/2011	US8034557 Diagnosing age related and cardiovascular disorders using variation in lamin a gene expression profiles; kits
10/11/2011	US8034554 Methods and compositions to detect nucleic acids in a biological sample
10/11/2011	US8034553 Biomarkers for wound healing
10/11/2011	US8034353 Peptide vaccine for inducing the production of anti-amyloid β-peptide antibody
10/11/2011	US8034349 Peptides that mimic non-human cross-reactive protective epitopes of the group B meningococcal capsular polysaccharide
10/11/2011	US8034348 Prevention and treatment of amyloidogenic disease
10/11/2011	US8034342 for treating degenerative cartilaginous disorders and other inflammatory diseases; interleukin-17 receptor protein
10/11/2011	US8034339 administering an antibody that specifically binds to the amyloid deposit or a component thereof; can be a human, humanized, chimeric or nonhuman antibody and can be monoclonal or polyclonal; also a novel monoclonal antibody which specifically binds to an epitope within residues 13-28 of A beta
10/11/2011	CA2468258C Peptide agonists of prostate-specific antigen, and uses therefor
10/11/2011	CA2442993C Nucleic acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
10/06/2011	WO2011123504A1 Glucose valve and other metabolite valves
10/06/2011	WO2011123473A1 Method for improving detection of b cell immunoglobulin gene recombination
10/06/2011	WO2011123468A1 Sirna therapy for transthyretin (ttr) related ocular amyloidosis
10/06/2011	WO2011123394A1 Modulation of matrix metalloproteinase 13 (mmp-13) expression
10/06/2011	WO2011120165A1 Macrocyclic lactone resistance marker for dirofilaria immitis
10/06/2011	WO2011095336A3 Post-synthetic modification of nucleic acids by inverse diels-alder reaction
10/06/2011	WO2011011463A3 Manipulation of an alternative respiratory pathway in photo-autotrophs
10/06/2011	US20110247101 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
10/06/2011	US20110247098 Plants Having Enhanced Abiotic Stress Tolerance and/or Enhanced Yield-Related Traits and a Method for Making the Same
10/06/2011	US20110247093 Induced heterosis related mutations
10/06/2011	US20110247090 Synthetic 5'UTRs, Expression Vectors, and Methods for Increasing Transgene Expression
10/06/2011	US20110247088 Tetracycline inducible transcription control sequence
10/06/2011	US20110245481 METHOD FOR INHIBITING FUNCTION OF micro-RNA
10/06/2011	US20110245480 Engineered listeria and methods of use thereof
10/06/2011	US20110245479 Method for Generating Aptamers with Improved Off-Rates
10/06/2011	US20110245478 Method for the Synthesis of Oligonucleotide Derivatives
10/06/2011	US20110245464 Highly thermostable fluorescent proteins
10/06/2011	US20110245462 Non-Fluorescent Quencher Compounds and Biomolecular Assays
10/06/2011	US20110245458 Peptide nucleic acid monomers and oligomers
10/06/2011	US20110245329 Double-stranded rna structures and constructs, and methods for generating and using the same

1 ... 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 ... 899